FI67698C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-aryloxi-2-hydroxi-3-aminopropaner - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-aryloxi-2-hydroxi-3-aminopropaner Download PDF

Info

Publication number
FI67698C
FI67698C FI771630A FI771630A FI67698C FI 67698 C FI67698 C FI 67698C FI 771630 A FI771630 A FI 771630A FI 771630 A FI771630 A FI 771630A FI 67698 C FI67698 C FI 67698C
Authority
FI
Finland
Prior art keywords
formula
phenyl
propoxy
group
hydroxy
Prior art date
Application number
FI771630A
Other languages
English (en)
Finnish (fi)
Other versions
FI771630A (no
FI67698B (fi
Inventor
Werner Fritsch
Ulrich Stache
Ernst Lindner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI771630A publication Critical patent/FI771630A/fi
Publication of FI67698B publication Critical patent/FI67698B/fi
Application granted granted Critical
Publication of FI67698C publication Critical patent/FI67698C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
FI771630A 1976-05-25 1977-05-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-aryloxi-2-hydroxi-3-aminopropaner FI67698C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2623314 1976-05-25
DE2623314A DE2623314C2 (de) 1976-05-25 1976-05-25 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
FI771630A FI771630A (no) 1977-11-26
FI67698B FI67698B (fi) 1985-01-31
FI67698C true FI67698C (fi) 1985-05-10

Family

ID=5978907

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771630A FI67698C (fi) 1976-05-25 1977-05-23 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-aryloxi-2-hydroxi-3-aminopropaner

Country Status (18)

Country Link
JP (1) JPS5312827A (no)
AT (1) AT354421B (no)
AU (1) AU511704B2 (no)
BE (1) BE855041A (no)
CA (1) CA1108633A (no)
CH (5) CH637105A5 (no)
DE (1) DE2623314C2 (no)
DK (1) DK227177A (no)
ES (1) ES458957A1 (no)
FI (1) FI67698C (no)
FR (1) FR2353520A1 (no)
GB (1) GB1577670A (no)
HU (1) HU179198B (no)
IL (1) IL52148A (no)
IT (1) IT1077193B (no)
NL (1) NL7705587A (no)
SE (1) SE440903B (no)
ZA (1) ZA773120B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415622A1 (fr) * 1978-01-25 1979-08-24 Lipha Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
IT1118835B (it) * 1978-08-15 1986-03-03 Smithkline Corp Procedimento per introdurre catene laterali di bloccaggio in nuclei aromatici contenenti un gruppo fenolico
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
JPH0629833B2 (ja) * 1984-06-15 1994-04-20 株式会社島津製作所 疲労試験機
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
CA2716369C (en) 1999-05-24 2013-05-14 Mitsubishi Tanabe Pharma Corporation Phenoxypropylamine compounds
DE19941657A1 (de) * 1999-09-01 2001-03-08 Schwabe Willmar Gmbh & Co Zimtsäurenitrile, Verfahren zu ihrer Herstellung und Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
FR2132570B1 (no) * 1971-04-09 1974-08-02 Lipha
BE791650R (fr) * 1971-11-18 1973-05-21 Ici Ltd Derives d'alkanolamines.
ES411826A1 (es) * 1973-02-20 1976-01-01 Liade Sa Lab Procedimiento de obtencion de 1-ariloxi - 2 - propanolami- nas farmacologicamente activos.

Also Published As

Publication number Publication date
CH637108A5 (en) 1983-07-15
AU511704B2 (en) 1980-09-04
BE855041A (fr) 1977-11-25
FR2353520A1 (fr) 1977-12-30
FR2353520B1 (no) 1980-07-25
AT354421B (de) 1979-01-10
CH637105A5 (en) 1983-07-15
FI771630A (no) 1977-11-26
SE440903B (sv) 1985-08-26
CH640507A5 (en) 1984-01-13
JPS5312827A (en) 1978-02-04
AU2543477A (en) 1978-11-30
CH637109A5 (en) 1983-07-15
CA1108633A (en) 1981-09-08
ZA773120B (en) 1978-04-26
FI67698B (fi) 1985-01-31
IL52148A0 (en) 1977-07-31
DE2623314A1 (de) 1977-12-08
JPS6214545B2 (no) 1987-04-02
GB1577670A (en) 1980-10-29
ATA370177A (de) 1979-06-15
NL7705587A (nl) 1977-11-29
DE2623314C2 (de) 1984-08-02
ES458957A1 (es) 1978-07-16
SE7706059L (sv) 1977-11-26
HU179198B (en) 1982-09-28
IT1077193B (it) 1985-05-04
DK227177A (da) 1977-11-26
CH637107A5 (en) 1983-07-15
IL52148A (en) 1982-07-30

Similar Documents

Publication Publication Date Title
US3655663A (en) 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
PL92131B1 (no)
FR2722788A1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
FI112649B (fi) Menetelmä terapeuttisesti käyttökelpoisten diamiiniyhdisteiden valmistamiseksi
US4191765A (en) 1-Aryloxy-2-hydroxy-3-aminopropanes
US4730042A (en) Compounds 1 or 3-hydroxy-4-benzyl-6-methyl-7-(4-isopropylamino-butoxy)-1,3-dihydro[3,4-C]pyridine and 2-methyl-3-(4-isopropyl-aminobutoxy)-4-(1'-morphilinomethyl)-5-hydroxymethyl-6-benzyl pyridine, useful for treating cardiac arrhythmias
FI67698C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-aryloxi-2-hydroxi-3-aminopropaner
EP0005828A1 (de) Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
US3974158A (en) 2-(Substituted anilino)methylmorpholines
FI62052B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta 2-mimetisk och/eller alfa 1-blockerande verkan
FR2459235A1 (fr) Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
EP0034284B1 (en) Piperazine derivative, processes for preparing the same and therapeutic compositions containing it
FI69835B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-ndolyl-tertiaerbutylaminopropanolderivat
US4064245A (en) N-Phenoxyphenyl-piperazines
GB2055360A (en) Benzimidazoles
GB1569251A (en) Pyridobenzodiazepines
US5077290A (en) Morpholine derivatives compositions and use
US3077470A (en) 3-[4-hydroxy-3-(aminomethyl)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
FI62060C (fi) Foerfarande foer framstaellning av beta-blockerande substituerad 2-hydroxi-3-(2-acyl-4-ureido-fenoxi)-propylaminderivat
SU428602A3 (ru) Способ получения основпозамещенных производных 1
DK160486B (da) N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition
US5128369A (en) Arylalkylamine derivatives
US4242343A (en) Phenylpiperazine derivatives
EP0011747A1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0034894A2 (en) 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, processes for their preparation, intermediates used in the processes and the preparation thereof and pharmaceutical compositions containing the derivatives

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT